Zimmer Biomet Financial Statements
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zimmer Biomet revenue and earnings
In fiscal 2025, Zimmer Biomet generated $8.23 billion in revenue, up 7.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $705.1 million (-22.0% year over year), for a net margin of 8.6% versus a median of 5.9% in the prior 5 years. Gross margin was 69.7% (down from 71.5%) and operating margin 13.3%.
Diluted earnings per share came in at $3.55, down from $4.43. Over the last 5 fiscal years, ZBH's revenue has grown at a 6.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Zimmer Biomet income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.23B | 7.68B | 7.39B | 6.94B | 6.83B | 6.13B | 7.98B | 7.93B | 7.80B | 7.67B |
| Revenue growth (YoY) | +7.20% | +3.85% | +6.55% | +1.65% | +11.42% | -23.24% | +0.62% | +1.66% | +1.76% | +27.85% |
| Cost of Revenue | 2.49B | 2.19B | 2.08B | 2.02B | 1.96B | 1.82B | 2.25B | 2.27B | 2.13B | 2.38B |
| Gross Profit | 5.74B | 5.49B | 5.31B | 4.92B | 4.87B | 4.30B | 5.73B | 5.66B | 5.67B | 5.29B |
| Operating Expenses | 4.64B | 4.20B | 4.03B | 4.22B | 4.01B | 4.22B | 4.59B | 5.63B | 4.87B | 4.47B |
| Research & Development | 458.50M | 437.40M | 458.70M | 406.00M | 435.80M | 322.80M | 449.30M | 391.70M | 369.90M | 365.60M |
| Selling, General & Admin | 3.26B | 2.93B | 2.84B | 2.76B | 2.84B | 2.71B | 3.34B | 3.38B | 3.10B | 2.94B |
| Operating Income | 1.10B | 1.29B | 1.28B | 696.30M | 860.30M | 83.10M | 1.14B | 33.80M | 799.30M | 821.10M |
| Interest Expense | — | — | — | — | — | — | — | — | 327.50M | 357.90M |
| Other Income (Expense) | 25.50M | -31.10M | -9.30M | -128.00M | 12.20M | 23.80M | -4.80M | -15.60M | -9.40M | -66.50M |
| Pretax Income | 830.80M | 1.04B | 1.07B | 403.50M | 499.00M | -105.20M | 905.80M | -271.10M | 464.60M | 399.60M |
| Income Tax | 125.70M | 131.40M | 42.20M | 112.30M | 53.50M | -96.00M | -225.70M | 108.20M | -1.35B | 95.00M |
| Net Income | 705.10M | 903.80M | 1.02B | 231.40M | 401.60M | -138.90M | 1.13B | -379.20M | 1.81B | 305.90M |
| Net Income growth (YoY) | -21.98% | -11.74% | +342.52% | -42.38% | — | -112.27% | — | -120.91% | +492.94% | +108.10% |
| EPS (Basic) | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 | -0.67 | 5.52 | -1.86 | 8.98 | 1.53 |
| EPS (Diluted) | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 | -0.67 | 5.47 | -1.86 | 8.90 | 1.51 |
| Shares Outstanding (Basic) | 198.00M | 203.10M | 208.70M | 209.60M | 208.60M | 207.00M | 205.10M | 203.50M | 201.90M | 200.00M |
| Shares Outstanding (Diluted) | 198.70M | 203.90M | 209.70M | 210.30M | 210.40M | 207.00M | 206.70M | 203.50M | 203.70M | 202.40M |
| EBITDA | 2.19B | 2.28B | 2.23B | 1.62B | 1.80B | 981.50M | 2.14B | 1.07B | 1.86B | 1.86B |
| Gross Margin | 69.71% | 71.46% | 71.82% | 70.90% | 71.29% | 70.23% | 71.78% | 71.36% | 72.67% | 68.94% |
| Operating Margin | 13.34% | 16.74% | 17.28% | 10.03% | 12.60% | 136.00% | 14.25% | 43.00% | 10.24% | 10.71% |
| Net Margin | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% | -2.27% | 14.18% | -4.78% | 23.24% | 3.99% |
This table shows 10 annual periods of Zimmer Biomet's income statement, from FY 2025 back to FY 2016, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ZBH's reporting calendar. What is a income statement?